Skip to main content

Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.

Publication ,  Journal Article
Morrison, JT; Canonico, ME; Anand, SS; Patel, MR; Debus, ES; Nehler, MR; Hess, CN; Hsia, J; Capell, WH; Muehlhofer, E; Haskell, LP; Bonaca, MP ...
Published in: Circulation
May 7, 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 7, 2024

Volume

149

Issue

19

Start / End Page

1536 / 1539

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Rivaroxaban
  • Platelet Aggregation Inhibitors
  • Peripheral Arterial Disease
  • Middle Aged
  • Male
  • Lower Extremity
  • Humans
  • Female
  • Factor Xa Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Morrison, J. T., Canonico, M. E., Anand, S. S., Patel, M. R., Debus, E. S., Nehler, M. R., … Bonaca, M. P. (2024). Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD. Circulation, 149(19), 1536–1539. https://doi.org/10.1161/CIRCULATIONAHA.124.068080
Morrison, Justin T., Mario Enrico Canonico, Sonia S. Anand, Manesh R. Patel, Eike Sebastian Debus, Mark R. Nehler, Connie N. Hess, et al. “Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.Circulation 149, no. 19 (May 7, 2024): 1536–39. https://doi.org/10.1161/CIRCULATIONAHA.124.068080.
Morrison, Justin T., et al. “Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.Circulation, vol. 149, no. 19, May 2024, pp. 1536–39. Pubmed, doi:10.1161/CIRCULATIONAHA.124.068080.
Morrison JT, Canonico ME, Anand SS, Patel MR, Debus ES, Nehler MR, Hess CN, Hsia J, Capell WH, Muehlhofer E, Haskell LP, Berkowitz SD, Bauersachs RM, Bonaca MP. Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD. Circulation. 2024 May 7;149(19):1536–1539.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 7, 2024

Volume

149

Issue

19

Start / End Page

1536 / 1539

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Rivaroxaban
  • Platelet Aggregation Inhibitors
  • Peripheral Arterial Disease
  • Middle Aged
  • Male
  • Lower Extremity
  • Humans
  • Female
  • Factor Xa Inhibitors